Current Heart Failure Reports,
Journal Year:
2024,
Volume and Issue:
21(2), P. 81 - 100
Published: Jan. 30, 2024
Abstract
Purpose
of
Review
This
review
explores
the
interplay
among
metabolic
dysfunction,
oxidative
stress,
inflammation,
and
fibrosis
in
Fabry
disease,
focusing
on
their
potential
implications
for
cardiac
involvement.
We
aim
to
discuss
biochemical
processes
that
operate
parallel
sphingolipid
accumulation
contribute
disease
pathogenesis,
emphasizing
importance
a
comprehensive
understanding
these
processes.
Recent
Findings
Beyond
accumulation,
emerging
studies
have
revealed
mitochondrial
chronic
inflammation
could
be
significant
contributors
These
factors
promote
remodeling
may
predispose
patients
conduction
disturbances,
ventricular
arrhythmias,
heart
failure.
While
current
treatments,
such
as
enzyme
replacement
therapy
pharmacological
chaperones,
address
progression
symptoms,
effectiveness
is
limited.
Summary
Our
uncovers
relationships
disease–related
complications.
Current
findings
suggest
beyond
other
mechanisms
significantly
pathogenesis.
prompts
exploration
innovative
therapeutic
strategies
underscores
holistic
approach
managing
disease.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Dec. 29, 2022
Sirtuins
(SIRTs)
are
nicotine
adenine
dinucleotide(+)-dependent
histone
deacetylases
regulating
critical
signaling
pathways
in
prokaryotes
and
eukaryotes,
involved
numerous
biological
processes.
Currently,
seven
mammalian
homologs
of
yeast
Sir2
named
SIRT1
to
SIRT7
have
been
identified.
Increasing
evidence
has
suggested
the
vital
roles
members
SIRT
family
health
disease
conditions.
Notably,
this
protein
plays
a
variety
important
cellular
biology
such
as
inflammation,
metabolism,
oxidative
stress,
apoptosis,
etc.,
thus,
it
is
considered
potential
therapeutic
target
for
different
kinds
pathologies
including
cancer,
cardiovascular
disease,
respiratory
other
Moreover,
identification
modulators
exploring
functions
these
prompted
increased
efforts
discover
new
small
molecules,
which
can
modify
activity.
Furthermore,
several
randomized
controlled
trials
indicated
that
interventions
might
affect
expression
human
samples,
supplementation
diverse
impact
on
physiological
function
participants.
In
review,
we
introduce
history
structure
family,
discuss
molecular
mechanisms
elaborate
regulatory
SIRTs
summarize
inhibitors
activators,
review
related
clinical
studies.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(13), P. 4982 - 4982
Published: June 25, 2023
Flavonoids
represent
the
main
class
of
plant
secondary
metabolites
and
occur
in
tissues
organs
various
species.
In
plants,
flavonoids
are
involved
many
biological
processes
response
to
environmental
stresses.
The
consumption
has
been
known
reduce
risk
chronic
diseases
due
their
antioxidant
free
radical
scavenging
properties.
present
review,
we
summarize
classification,
distribution,
biosynthesis
pathways,
regulatory
mechanisms
flavonoids.
Moreover,
investigated
activities
discuss
applications
food
processing
cosmetics,
as
well
pharmaceutical
medical
uses.
Current
trends
flavonoid
research
also
briefly
described,
including
mining
new
functional
genes
through
omics
engineering
using
nanotechnology.
This
review
provides
a
reference
for
basic
applied
on
compounds.
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 2, 2023
Abstract
Cardiovascular
diseases
(CVDs)
continue
to
exert
a
significant
impact
on
global
mortality
rates,
encompassing
conditions
like
pulmonary
arterial
hypertension
(PAH),
atherosclerosis
(AS),
and
myocardial
infarction
(MI).
Oxidative
stress
(OS)
plays
crucial
role
in
the
pathogenesis
advancement
of
CVDs,
highlighting
its
significance
as
contributing
factor.
Maintaining
an
equilibrium
between
reactive
oxygen
species
(ROS)
antioxidant
systems
not
only
aids
mitigating
oxidative
but
also
confers
protective
benefits
cardiac
health.
Herbal
monomers
can
inhibit
OS
CVDs
by
activating
multiple
signaling
pathways,
such
increasing
activity
endogenous
decreasing
level
ROS
expression.
Given
actions
herbal
significantly
protect
normal
function
heart
reduce
damage
caused
organism.
Hence,
it
is
imperative
recognize
prospective
therapeutic
interventions
for
CVDs.
This
paper
aims
comprehensively
review
origins
mechanisms
underlying
OS,
elucidate
intricate
association
explore
potential
treatment
utilizing
monomers.
Furthermore,
particular
emphasis
will
be
placed
examining
cardioprotective
effects
evaluating
their
pathways
subsequent
treatment.
Graphical
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(5), P. 2496 - 2517
Published: March 6, 2024
Abstract
We
investigated
the
mechanism
by
which
quercetin
preserves
mitochondrial
quality
control
(MQC)
in
cardiomyocytes
subjected
to
ischemia–reperfusion
stress.
An
enzyme‐linked
immunosorbent
assay
was
employed
vivo
experiments
assess
myocardial
injury
markers,
measure
transcript
levels
of
SIRT5/DNAPK‐cs/MLKL
during
various
time
intervals
ischemia–reperfusion,
and
observe
structural
changes
using
transmission
electron
microscopy.
In
vitro
investigations,
adenovirus
transfection
establish
a
gene‐modified
model
DNA‐PKcs,
primary
were
obtained
from
mouse
with
modified
SIRT5
gene.
Reverse
transcription
polymerase
chain
reaction,
laser
confocal
microscopy,
immunofluorescence
localization,
JC‐1
fluorescence
assay,
Seahorse
energy
analysis,
other
assays
applied
corroborate
regulatory
influence
on
MQC
network
after
ischemia–reperfusion.
demonstrated
that
caused
structure
myocardium.
It
seen
had
beneficial
effect
tissue,
providing
protection.
As
process
continued,
DNA‐PKcs/SIRT5/MLKL
transcripts
also
found
change.
investigations
revealed
mitigated
cardiomyocyte
oxidative
stress
through
regulated
mitophagy
kinetics
sustain
optimal
metabolism
levels.
Quercetin,
desuccinylation,
modulated
stability
together
they
“mitophagy‐unfolded
protein
response.”
This
preserved
integrity
membrane
genome,
dynamics,
metabolism.
Quercetin
may
operate
synergistically
oversee
regulation
unfolded
response
DNA‐PKcs‐SIRT5
interaction.
Cardiovascular Research,
Journal Year:
2022,
Volume and Issue:
118(18), P. 3556 - 3575
Published: Dec. 7, 2022
Heart
failure
(HF)
is
marked
by
distinctive
changes
in
myocardial
uptake
and
utilization
of
energy
substrates.
Among
the
different
types
HF,
HF
with
preserved
ejection
fraction
(HFpEF)
a
highly
prevalent,
complex,
heterogeneous
condition
for
which
metabolic
derangements
seem
to
dictate
disease
progression.
Changes
intermediate
metabolism
cardiometabolic
HFpEF-among
most
prevalent
forms
HFpEF-have
large
impact
both
on
provision
number
signalling
pathways
heart.
This
dual,
vs.
signalling,
role
played
particular
long-chain
fatty
acids
(LCFAs)
short-chain
carbon
sources
[namely,
(SCFAs)
ketone
bodies
(KBs)].
LCFAs
are
key
fuels
heart,
but
their
excess
can
be
harmful,
as
case
toxic
accumulation
lipid
by-products
(i.e.
lipotoxicity).
SCFAs
KBs
have
been
proposed
potential
major,
alternative
source
HFpEF.
At
same
time,
substrate
protein
post-translational
modifications
other
direct
indirect
pivotal
importance
HFpEF
pathogenesis.
An
in-depth
molecular
understanding
biological
functions
substrates
will
instrumental
development
novel
therapeutic
approaches
Here,
we
summarize
current
evidence
HFpEF,
discuss
metabolites
through,
at
least
part,
fate
modifications,
highlight
clinical
translational
challenges
around
therapy
Frontiers in Cardiovascular Medicine,
Journal Year:
2022,
Volume and Issue:
9
Published: June 17, 2022
Mitochondria
play
a
key
role
in
cellular
metabolism.
Mitochondrial
dynamics
(fusion
and
fission)
mitophagy,
are
critical
to
mitochondrial
function.
Fusion
allows
organelles
share
metabolites,
proteins,
DNA,
promoting
complementarity
between
damaged
mitochondria.
Fission
increases
the
number
of
mitochondria
ensure
that
they
passed
on
their
offspring
during
mitosis.
Mitophagy
is
process
selective
removal
excess
or
helps
improve
energy
Cardiometabolic
disease
characterized
by
dysfunction,
high
production
reactive
oxygen
species,
increased
inflammatory
response,
low
levels
ATP.
closely
related
mitophagy.
This
paper
reviewed
mechanisms
mitophagy
(focus
MFN1,
MFN2,
OPA1,
DRP1,
PINK1
proteins)
roles
diabetic
cardiomyopathy,
myocardial
infarction,
cardiac
hypertrophy,
heart
failure,
atherosclerosis,
obesity.